Fulgent GeneticsvsJohnson & Johnson

FLGT and JNJ stock compared: price, dividend, valuation and results, from SEC filings.

FLGT

Fulgent Genetics, Inc.

$24.77

Value $692M

-1.43%
FLGT's page

Fulgent Genetics (FLGT) has a market value of $692M and Johnson & Johnson (JNJ) $642B. Over the last year, with dividends, FLGT moved -14.9% and JNJ +36.2%. Dividend yield: FLGT none, JNJ 1.98%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    FLGT$692M

    JNJ$642B

    JNJ is 928 times FLGT

  • Revenue, 12 months

    FLGT$330M

    JNJ$99.3B

    JNJ is 301 times FLGT

  • Net income, 12 months

    FLGT-$91M

    JNJ$16.1B

  • Operating margin

    FLGT-39.2%

    JNJ–

  • ROIC

    FLGT-9.7%

    JNJ12.4%

    22.1 points apart

  • P/E

    FLGT–

    JNJ39.9

  • Dividend yield

    FLGT0.0%

    JNJ2.0%

    2.0 points apart

  • 5-year return

    FLGT-73.5%

    JNJ+88.6%

    162.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

FLGT-73.5%

JNJ+88.6%

10020020222023202420252026
Returns by period
PeriodFLGTWith dividendsJNJWith dividends
1 year since November 18, 2025-14.9%Price -14.9%+36.2%Price +33.2%
3 years since November 17, 2023-8.5%-2.9% a yearPrice -8.5%+93.7%+24.6% a yearPrice +77.9%
5 years since November 18, 2021-73.5%-23.3% a yearPrice -73.5%+88.6%+13.5% a yearPrice +64.0%
10 years since November 21, 2016+178.6%+10.8% a yearPrice +178.6%+201.9%+11.7% a yearPrice +131.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

FLGTFulgent GeneticsJNJJohnson & Johnson

Valuation

FLGTJNJ
Valuation
Price$24.77$266.44
Market value$692M$642B
Enterprise value (EV)$401M$670B
P/E–39.9
P/E, 5-year median–21.9
P/B0.77.9
EV/EBIT–37.8
Free cash flow yield–3.2%

Results and growth

FLGTJNJ
Results and growth
Revenue, 12 months$330M$99.3B
Net income, 12 months-$91M$16.1B
Free cash flow, 12 months-$1.4M$20.6B
Earnings per share, 12 months-$2.91$6.59
Revenue growth, year on year13.8%6.1%
Revenue growth a year, past-5.2%over 5 years+2.7%over 5 years
EPS growth a year, past–+14.9%over 5 years

Margins and returns on capital

FLGTJNJ
Margins and returns on capital
Gross margin33.8%67.6%
Operating margin-39.2%–
Net margin-27.5%16.2%
ROIC-9.7%12.4%
ROE-8.6%19.7%

Balance sheet

FLGTJNJ
Balance sheet
Cash$293M$17.2B
Total debt$10M$44.7B
Net debt / EBITDA–1.1
Interest cover-1,307.9×18.0×

Dividends and buybacks

FLGTJNJ
Dividends and buybacks
Dividend yield–2.0%
Dividend per share, 12 months–$5.28
Dividend growth a year, past–+5.3%over 5 years
Buyback yield1.6%0.9%
Shareholder yield1.6%2.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: FLGT or JNJ

Didn't find what you were looking for?

Ask us
Which is bigger, Fulgent Genetics or Johnson & Johnson?

By market value, Johnson & Johnson ($642B) is about 927.8 times Fulgent Genetics ($692M), at today's prices.

How did FLGT and JNJ stock do over the last 10 years?

Since November 21, 2016, FLGT's price moved +178.6% and JNJ's +131.7%. With dividends: FLGT +178.6% (+10.8% a year), JNJ +201.9% (+11.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, FLGT or JNJ?

The dividend yield at today's price is none for Fulgent Genetics and 1.98% for Johnson & Johnson. Over the last twelve months they paid – and $5.28 per share.

Which has the higher profit margins, Fulgent Genetics or Johnson & Johnson?

Over the last twelve months, the net margin was -27.5% for Fulgent Genetics and 16.2% for Johnson & Johnson, and the operating margin -39.2% and –. Revenue was $330M and $99.3B.

Which is the better investment, Fulgent Genetics or Johnson & Johnson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.